Skymount Medical to Receive Silver Stevie Award from the Annual American Business Awards

Skymount Medical has been awarded a Silver Stevie ® Award in the Artificial Intelligence / Machine Learning Solution category of the 20th annual American Business Awards. This award is based on the company’s work developing its DeepDrug™ AI platform. 

The company utilized an AI platform developed by Louisiana State University (LSU) researchers to repurpose and build new drugs for innovative new therapies. Their DeepDrug™ AI platform is designed to accelerate drug discovery and development for the entire industry. 

Alongside this platform, the company is working on developing combination therapies to fight COVID-19 and all coronavirus strains. Their focus extends to other infectious diseases as well as new antibiotics that target antibiotic-resistant bacteria and rare diseases.

The American Business Awards is the premier business awards program in the United States. All organizations operating in the U.S. are eligible to submit nominations, whether they are public or private, for-profit or non-profit, large or small.

“We are honored and gratified to be among the elite group of companies recognized for their achievements,” said Zubin Kothawala, chief executive officer of Skymount Medical. “It is especially meaningful that the judges’ comments included words like ‘revolutionary’ and ‘sophisticated’ when describing our computer-aided drug design software that uses key components to deliver an efficient, state-of-the-art compound generation that significantly shortens the timelines and reduces the cost for new drug development. Receiving this prestigious award validates our commitment to the important work of advancing the development of improved medicines using DeepDrug™ and providing greater access to cutting-edge therapeutics.”

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at or contact your usual Swanson Reed representative.

Recent Posts